Case Study

Submitted By

Athish Vikraman

PGDHR

Batch “DH 16”

CONTENTS

1. | Ranbaxy’s Timeline |

2. | Question 1Was Brar’s decision to step down as the CEO a forced one or a personal choice ? * Background Info * Analysis of Data * Conclusion |

3. | Question 2Between Tempest & Malvinder who will be a better successor at Ranbaxy & why ? * Profile Comparison * Analysis of Data * Conclusion |

Ranbaxy's Time Line |

| | | | |

|   | 1952 |   | • Ranbaxy founded by Bhai Mohan Singh |

| | | | • The Co. was mainly engaged in reverse engineering other drugs |

| | | | |

• Dr. Parvinder Singh,

the son of B.M. Singh joins the Co. |   | 1967 |   | |

| | | | |

|   | 1977 |   | • Brar joins Ranbaxy as Business Development Manager. |

| | | | • Becomes a close confident of Dr. Singh |

| |   | | |

• Dr. Singh becomes MD |   | 1982 |   | |

• Brar become GM for 2 divisions

(Animal Healthcare & International) | | | | |

| | | | |

• Ranbaxy turnover reaches 360 million | | | | |

• Market Capitalization reaches 35 million | | | | |

| | | | |

| | 1986 |   | • Brar becomes GM of Pharma (Head) & also takes charge of chemicals division |

| |   | | |

• 2 Family Bhai Manjit Singh & Analjit Singh leaves the Co. |   | 1989 |   | |

• Brar becomes Senior VP | | | | |

| | | | |

|   | 1993 |   | • Dr.Singh takes full control of the Co. |

| | | | • B.M. Singh Retires |

| | | | • Brar becomes President Pharma leads Ranbaxy's Global trust |

| | | | • Dr.Singh sets goal to reach 1 billion by 2004 |

| | | | |

• Differences arises between Dr.Singh & B.M.Singh |   | Early

90's |   | |

over growth route of the Co. | | | | |

• Dr.Singh wants to invest huge in R&D

& expand operations to other countries | | | | |

• Brar Supports Dr. Singh's Vision | | | | |

| | | | |

|   | 1995 |   | •...